Código QR (código de barras bidimensional)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION

Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by progressive increase in pulmonary vascular resistance (PVR), higher pulmonary arteries mean pressure (mPAP), decrease in cardiac minute output (CMO) and other hemodynamic, functional and biochemical disorders. Exist...

Fuld beskrivelse

Na minha lista:
Principais autores: E. A. Devetyarova, A. A. Dyuzhikov, A. A. Dyuzhikova, S. V. Sobin, A. V. Sumin, E. V. Pashchenko
Format: Artigo
Sprog:Russo
Udgivet: InterMedservice 2018-06-01
Serier:Евразийский Кардиологический Журнал
Fag:
pulmonary hypertension
pulmonary arterial hypertension
riociguat
bosentan
therapy
Online adgang:https://www.heartj.asia/jour/article/view/287
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker